- $6.42bn
- $8.14bn
- $3.80bn
Annual income statement for JBT Marel, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,401 | 1,590 | 1,664 | 1,716 | 3,798 |
| Cost of Revenue | |||||
| Gross Profit | 482 | 529 | 586 | 627 | 1,335 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,275 | 1,458 | 1,500 | 1,598 | 3,609 |
| Operating Profit | 126 | 133 | 165 | 118 | 189 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 120 | 120 | 153 | 95.4 | -62.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 92.5 | 104 | 129 | 84.7 | -49.3 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 119 | 137 | 583 | 85.4 | -50.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 119 | 137 | 583 | 85.4 | -50.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.23 | 3.74 | 4.49 | 6.06 | 3.37 |
| Dividends per Share |